Thinking Ahead ieso

AI has existed in some form for decades and is now beginning to enter many areas of our lives. And relatively recently, its use has begun in healthcare.
Mental health is an area of healthcare in which its adoption is advancing rapidly.
But why is that? How does it help, exactly?
Join us as we talk to Dr Ronan Cummins, Dr Jennifer Gentile, and Dr Michael Ewbank. Listen to them describe what they’ve learned from their work at ieso, which uses AI to improve patient outcomes for therapists treating mental health conditions. They explain how they're improved and could improve further as technology advances.

AI, machine learning, natural language processing – what are they, how do they differ, and how are they used to help with therapy?

What’s the difference between human-in-the-loop AI-augmented therapy and automated chatbots?

What does the future hold for AI and therapy – could it ever be entirely automated?


More about ieso’s mission and plans for the future - here
Subscribe on your podcast player so you never miss an episode

What are the new subtypes of depression ieso’s Director of Clinical Science, Dr Ana Catarino has identified in her fascinating, data-driven research? And how will these insights personalise treatment pathways and increase patient recovery rates? 
Join us as we talk to Dr Catarino, Dr Mel Simmonds-Buckley (of Sheffield University’s Clinical Psychology Unit) and Dr Jennifer Gentile (ieso’s SVP of US Research and Clinical Innovation), about ieso and the Sheffield University’s seminal research into subtypes of depression and their varying responses to treatment.

Why are these new categories more robust than earlier attempts to categorise depression?

How has Dr Mel Simmonds-Buckley’s research on face-to-face (as opposed to text-enabled) patients helped corroborate and further sub-divide Dr Catarino’s game-changing insights?

Why do our guests think this research will help recovery rates finally move above the 50% mark they have remained at for decades?


More about Dr Catarino’s research - here
More about ieso’s mission and plans for the future - here
Subscribe on your podcast player so you never miss an episode

How do we know when therapy works? And what does research published by ieso’s Senior Clinical Scientist, Dr Michael Ewbank, reveal about which elements of therapy are most impactful?
Joining host Tom Clelford to discuss this are Dr Jennifer Gentile (SVP of US Research and Clinical Innovation at ieso and a practicing clinician in the US), Dr Ana Catarino (Director of Clinical Science at ieso) and Dr Ewbank himself. 

What objective measurements can we take before and after therapy to determine its effectiveness?

When it comes to talking therapy sessions, how have advances in AI and deep learning helped us identify the “active ingredients” of therapy – the exact language that is making a therapeutic change occur?

How has ieso been able to extract insights from its 460,000-therapy hour dataset?

What data, other than the therapy session transcripts, does ieso have that further improves the quality of our therapy dataset?

How important is the rapport between patient and therapist? What about empathy? 

How can we tell that talking therapy interventions are more effective than merely chatting?

Why is ieso’s AI-powered, data-driven therapy supervision tool so much more accurate than human-only quality control?


Read Dr Ewbank’s JAMA paper: 'Quantifying the Association Between Psychotherapy Content and Clinical Outcomes Using Deep Learning' - here
Find out ,ore about ieso’s mission and future plans here
Subscribe on your podcast player so you never miss an episode

How does a business with a clear social purpose scale without sacrificing quality? And what role can AI and technology play in this? 
In this episode we talk to ieso’s CEO, Dr Nigel Pitchford, about the mental health tech company’s ambitious scaling strategy. 

How is ieso going to positively impact the mental health of 100 million lives in the next 5 years?

How can this be done without increasing its pool of therapists?

How will it make sure it retains its industry-leading recovery rates?

What’s the significance of ieso’s vast mental health dataset – the largest in the world?


Find our more about ieso’s mission and plans for the future: https://www.iesogroup.com/about-us
Find out more about Nigel: https://www.iesogroup.com/team/nigel-pitchford
Find out more about ieso: https://www.iesogroup.com
If you have any questions about any of the research or topics, email us: info@iesohealth.com

Follow us in your podcast player so you never miss an episode

Whether you’re a tech and science aficionado, a clinician, academic, healthcare professional, investor… Or you just like psychology, big data, AI, science and technology and love to keep up to date with the latest breakthroughs, this is the podcast for you.